Variant report

Variant	nsv834301
Chromosome Location	chr2:96285762-96427246
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr2:96394384-96394976	HepG2	liver:	n/a	n/a
2	BATF	chr2:96389629-96389835	GM12878	blood:	n/a	n/a
3	BATF	chr2:96373017-96373229	GM12878	blood:	n/a	chr2:96373152-96373163
4	BATF	chr2:96389586-96389891	GM12878	blood:	n/a	n/a
5	BATF	chr2:96373042-96373284	GM12878	blood:	n/a	chr2:96373152-96373163
6	BATF	chr2:96321288-96321485	GM12878	blood:	n/a	n/a
7	BATF	chr2:96401104-96401456	GM12878	blood:	n/a	n/a
8	BCL11A	chr2:96401104-96401290	GM12878	blood:	n/a	n/a
9	BCL11A	chr2:96401015-96401259	GM12878	blood:	n/a	n/a
10	BHLHE40	chr2:96394763-96394892	GM12878	blood:	n/a	n/a
11	CBX3	chr2:96321197-96321572	K562	blood:	n/a	n/a
12	CEBPB	chr2:96426902-96427182	MCF-7	breast:	n/a	chr2:96427040-96427051
13	CEBPB	chr2:96391404-96391735	IMR90	lung:	n/a	n/a
14	CEBPB	chr2:96394289-96395327	IMR90	lung:	n/a	chr2:96394419-96394430 chr2:96394419-96394432
15	CEBPB	chr2:96394271-96395330	HepG2	liver:	n/a	chr2:96394419-96394430 chr2:96394419-96394432
16	CEBPB	chr2:96361449-96361668	K562	blood:	n/a	n/a
17	CEBPB	chr2:96352290-96352412	HepG2	liver:	n/a	chr2:96352336-96352349 chr2:96352338-96352349 chr2:96352336-96352347 chr2:96352336-96352349
18	CEBPB	chr2:96394342-96395320	A549	lung:	n/a	chr2:96394419-96394430 chr2:96394419-96394432
19	CEBPB	chr2:96352196-96352515	A549	lung:	n/a	chr2:96352336-96352349 chr2:96352338-96352349 chr2:96352336-96352347 chr2:96352336-96352349
20	CEBPB	chr2:96353649-96353979	IMR90	lung:	n/a	n/a
21	CEBPB	chr2:96352152-96352528	IMR90	lung:	n/a	chr2:96352336-96352349 chr2:96352338-96352349 chr2:96352336-96352347 chr2:96352336-96352349
22	CEBPB	chr2:96426837-96427246	IMR90	lung:	n/a	chr2:96427040-96427051
23	CEBPB	chr2:96394684-96394919	HepG2	liver:	n/a	n/a
24	CEBPB	chr2:96394316-96394473	K562	blood:	n/a	chr2:96394419-96394430 chr2:96394419-96394432
25	CEBPB	chr2:96307480-96307731	IMR90	lung:	n/a	n/a
26	CEBPB	chr2:96352310-96352556	MCF-7	breast:	n/a	chr2:96352336-96352349 chr2:96352338-96352349 chr2:96352336-96352347 chr2:96352336-96352349
27	CEBPB	chr2:96321434-96321760	HepG2	liver:	n/a	n/a
28	CEBPB	chr2:96394709-96395335	K562	blood:	n/a	n/a
29	CEBPB	chr2:96352308-96352398	Hela-S3	cervix:	n/a	chr2:96352336-96352349 chr2:96352338-96352349 chr2:96352336-96352347 chr2:96352336-96352349
30	CEBPB	chr2:96321444-96322064	IMR90	lung:	n/a	n/a
31	CEBPB	chr2:96352306-96352520	A549	lung:	n/a	chr2:96352336-96352349 chr2:96352338-96352349 chr2:96352336-96352347 chr2:96352336-96352349
32	CEBPB	chr2:96394654-96395269	Hela-S3	cervix:	n/a	n/a
33	CEBPB	chr2:96426884-96427208	Hela-S3	cervix:	n/a	chr2:96427040-96427051
34	CEBPB	chr2:96426939-96427088	HepG2	liver:	n/a	chr2:96427040-96427051
35	CEBPB	chr2:96321559-96321605	K562	blood:	n/a	n/a
36	CTCF	chr2:96394724-96394994	Fibrobl	skin:	n/a	chr2:96394849-96394870 chr2:96394854-96394872
37	CTCF	chr2:96394686-96394694	LNCaP	prostate:	n/a	n/a
38	CTCF	chr2:96394719-96394996	HUVEC	blood vessel:	n/a	chr2:96394849-96394870 chr2:96394854-96394872
39	CTCF	chr2:96394759-96394962	GM13976	blood:	n/a	chr2:96394849-96394870 chr2:96394854-96394872
40	CTCF	chr2:96332514-96332648	HepG2	liver:	n/a	chr2:96332581-96332590 chr2:96332578-96332596 chr2:96332580-96332601
41	CTCF	chr2:96332540-96332690	BJ	skin:	n/a	chr2:96332581-96332590 chr2:96332578-96332596 chr2:96332580-96332601
42	CTCF	chr2:96332560-96332710	HRPEpiC	eye:	n/a	chr2:96332581-96332590 chr2:96332578-96332596 chr2:96332580-96332601
43	CTCF	chr2:96321269-96321508	Hela-S3	cervix:	n/a	chr2:96321387-96321408 chr2:96321385-96321398 chr2:96321388-96321397 chr2:96321385-96321403
44	CTCF	chr2:96394780-96394930	GM12867	blood:	n/a	chr2:96394849-96394870 chr2:96394854-96394872
45	CTCF	chr2:96343800-96343851	GM19240	blood:	n/a	chr2:96343803-96343816 chr2:96343801-96343819 chr2:96343802-96343818
46	CTCF	chr2:96321276-96321500	GM10266	blood:	n/a	chr2:96321387-96321408 chr2:96321385-96321398 chr2:96321388-96321397 chr2:96321385-96321403
47	CTCF	chr2:96321580-96321730	HCM	heart:	n/a	n/a
48	CTCF	chr2:96332520-96332670	Hela-S3	cervix:	n/a	chr2:96332581-96332590 chr2:96332578-96332596 chr2:96332580-96332601
49	CTCF	chr2:96332500-96332650	HMEC	breast:	n/a	chr2:96332581-96332590 chr2:96332578-96332596 chr2:96332580-96332601
50	CTCF	chr2:96394646-96394995	T-47D	breast:	n/a	chr2:96394849-96394870 chr2:96394854-96394872

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr2:96315229-96315279	BJ	skin:	n/a
2	chr2:96315229-96315279	BJ	skin:	n/a
3	chr2:96314847-96314897	HCPEpiC	choroid plexus:	n/a
4	chr2:96348691-96348741	HEK293	kidney:	embryo
5	chr2:96315229-96315279	GM19239	blood:	n/a
6	chr2:96427173-96427223	T-47D	breast:	n/a
7	chr2:96348691-96348741	NB4	blood:	n/a
8	chr2:96314847-96314897	SK-N-MC	brain:	n/a
9	chr2:96348691-96348741	HL-60	blood:	n/a
10	chr2:96315229-96315279	AG04450	lung:	fetal
11	chr2:96315200-96315250	HRPEpiC	eye:	n/a
12	chr2:96327674-96327724	HNPCEpiC	eye:	n/a
13	chr2:96348691-96348741	AG04450	lung:	fetal
14	chr2:96316743-96316793	A549	lung:	n/a
15	chr2:96427173-96427223	A549	lung:	n/a
16	chr2:96348691-96348741	Hela-S3	cervix:	n/a
17	chr2:96315200-96315250	HRCEpiC	kidney:	n/a
18	chr2:96315229-96315279	BE2_C	brain:	n/a
19	chr2:96316743-96316793	GM06990	blood:	n/a
20	chr2:96316743-96316793	HRPEpiC	eye:	n/a
21	chr2:96327674-96327724	PFSK-1	brain:	n/a
22	chr2:96314847-96314897	GM12878	blood:	n/a
23	chr2:96316743-96316793	NHDF-neo	bronchial:	n/a
24	chr2:96348691-96348741	MCF-7	breast:	n/a
25	chr2:96348691-96348741	HPAEpiC	pulmonary alveolar:	n/a
26	chr2:96315229-96315279	AG09319	gingival:	n/a
27	chr2:96327674-96327724	GM19239	blood:	n/a
28	chr2:96315229-96315279	Caco-2	colon:	n/a
29	chr2:96327674-96327724	HUVEC	blood vessel:	n/a
30	chr2:96315200-96315250	BE2_C	brain:	n/a
31	chr2:96315200-96315250	SK-N-SH_RA	brain:	n/a
32	chr2:96308242-96308292	A549	lung:	n/a
33	chr2:96316743-96316793	T-47D	breast:	n/a
34	chr2:96315200-96315250	PANC-1	pancreas:	n/a
35	chr2:96308242-96308292	NB4	blood:	n/a
36	chr2:96315229-96315279	GM12892	blood:	n/a
37	chr2:96427173-96427223	ECC-1	luminal epithelium:	n/a
38	chr2:96315200-96315250	K562	blood:	n/a
39	chr2:96315200-96315250	HEEpiC	esophagus:	n/a
40	chr2:96348691-96348741	LNCaP	prostate:	n/a
41	chr2:96427173-96427223	GM06990	blood:	n/a
42	chr2:96327674-96327724	AG04449	skin:	fetal
43	chr2:96316743-96316793	HL-60	blood:	n/a
44	chr2:96327674-96327724	BE2_C	brain:	n/a
45	chr2:96316743-96316793	CMK	blood:	n/a
46	chr2:96315229-96315279	HCF	heart:	n/a
47	chr2:96315200-96315250	GM06990	blood:	n/a
48	chr2:96348691-96348741	ProgFib	skin:	n/a
49	chr2:96315229-96315279	AG10803	skin:	n/a
50	chr2:96427173-96427223	AG09319	gingival:	n/a

No.	Distal block	Cell Line	Cell type
1	chr2:96054886..96055732-chr2:96394556..96395496,2	MCF-7	breast:
2	chr2:96058513..96059040-chr2:96394487..96395166,2	MCF-7	breast:
3	chr2:96406055..96406842-chr2:114139694..114140465,2	MCF-7	breast:
4	chr2:96362570..96365117-chr2:96367359..96369981,2	MCF-7	breast:
5	chr2:96079865..96080377-chr2:96394455..96395330,2	K562	blood:
6	chr2:96054639..96055198-chr2:96394784..96395584,2	K562	blood:
7	chr2:96362570..96365117-chr2:96367359..96369981,2	MCF-7	breast:
8	chr2:96054634..96055511-chr2:96394406..96395211,2	MCF-7	breast:
9	chr13:60970490..60971024-chr2:96378837..96379342,2	NB4	blood:
10	chr2:96011050..96011912-chr2:96394384..96395342,2	MCF-7	breast:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-TRIM43-1	chr2:96331832-96332151	ENSG00000235584
2	lnc-ANKRD36C-6	chr2:96305929-96306352	NONHSAT072504
3	lnc-TRIM43-1	chr2:96333664-96334497	NONHSAT072506
4	lnc-TRIM43-1	chr2:96331832-96332151	XLOC_001575
5	lnc-ANKRD36C-2	chr2:96383793-96384234	XLOC_002206
6	lnc-ANKRD36C-5	chr2:96307382-96307728	NONHSAT072505
7	lnc-TRIM43-1	chr2:96333665-96334010	ENSG00000235584
8	lnc-TRIM43-1	chr2:96331828-96332172	NONHSAT072506
9	lnc-TRIM43-1	chr2:96333665-96334463	XLOC_001575
10	lnc-ANKRD36C-2	chr2:96379286-96379320	XLOC_002206

Variant related genes	Relation type
ENSG00000235959	TF binding region
UBTFL3	TF binding region
ENSG00000236750	TF binding region
ENSG00000235584	TF binding region
ENSG00000235959	CpG island
UBTFL3	CpG island
ENSG00000236750	CpG island
ENSG00000235584	CpG island
ENSG00000248821	chromatin interactions
ENSG00000083544	chromatin interactions

Extended variants
information (count: 2806 )
Associated
traits (count: 54 )

Variant overlapped rSNPs/rCNVs (count:2806 , 50 per page) page: 1 2 3 4 5 6 7 ... 57

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs542583768	chr2:96305411-96305412	Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs560917276	chr2:96305422-96305423	Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs530051124	chr2:96305449-96305450	Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs540117645	chr2:96305490-96305491	Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs560152346	chr2:96305531-96305532	Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs532341213	chr2:96305553-96305554	Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs373730276	chr2:96305635-96305636	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs552278040	chr2:96305681-96305682	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs569292057	chr2:96305757-96305758	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs531700048	chr2:96306490-96306491	Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs548809687	chr2:96306517-96306518	Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs373800345	chr2:96306566-96306567	Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs568536670	chr2:96306567-96306568	Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs534530530	chr2:96306570-96306571	Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs578120531	chr2:96306935-96306936	Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs2551265	chr2:96307537-96307538	Enhancers	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
17	rs566495968	chr2:96307571-96307572	Enhancers	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
18	rs538591701	chr2:96307633-96307634	Enhancers	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
19	rs376055970	chr2:96307670-96307671	Enhancers	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
20	rs558379298	chr2:96307690-96307691	Enhancers	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
21	rs575337648	chr2:96307693-96307694	Enhancers	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
22	rs543970229	chr2:96307739-96307740	Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
23	rs2551267	chr2:96307783-96307784	Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
24	rs554777514	chr2:96307854-96307855	Enhancers Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
25	rs574279605	chr2:96307986-96307987	Enhancers Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
26	rs540154076	chr2:96308152-96308153	Enhancers Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
27	rs559990026	chr2:96308177-96308178	Enhancers Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
28	rs532376543	chr2:96308196-96308197	Enhancers Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
29	rs182648940	chr2:96308243-96308244	Enhancers Weak transcription	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
30	rs149393745	chr2:96308288-96308289	Enhancers Weak transcription	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
31	rs531858969	chr2:96308320-96308321	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs2551269	chr2:96308339-96308340	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs187707526	chr2:96308349-96308350	Enhancers Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
34	rs568653460	chr2:96308372-96308373	Enhancers Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
35	rs527857078	chr2:96308378-96308379	Enhancers Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
36	rs548112770	chr2:96308400-96308401	Enhancers Weak transcription	TF binding region	2 gene(s)	Overlapped CNVs	n/a
37	rs571118742	chr2:96308467-96308468	Weak transcription Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
38	rs540128020	chr2:96308639-96308640	Weak transcription Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
39	rs558571496	chr2:96308680-96308681	Weak transcription Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
40	rs568738061	chr2:96308688-96308689	Weak transcription Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
41	rs371560988	chr2:96308713-96308714	Weak transcription Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
42	rs111729510	chr2:96308767-96308768	Weak transcription Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
43	rs537982640	chr2:96308787-96308788	Weak transcription Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
44	rs201943844	chr2:96308931-96308932	Weak transcription Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
45	rs199850766	chr2:96309229-96309230	Weak transcription Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
46	rs574317729	chr2:96309367-96309368	Weak transcription Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
47	rs199972412	chr2:96309385-96309386	Weak transcription Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
48	rs2551270	chr2:96309519-96309520	Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
49	rs2551271	chr2:96309547-96309548	Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
50	rs192555311	chr2:96309553-96309554	Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:54)

Disease	PMID	Source
Medulloblastoma	21979893	CNVD
Breast cancer	17603634	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Ependymoma	16718352	CNVD
Prostate cancer	18632612	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Cancer	20164919	CNVD
Autism	17483303	CNVD
Medulloblastoma	20607354	CNVD
Autism	22495311	CNVD
Autism	18522746	CNVD
Neurodevelopmental disorder	22521361	CNVD
Melanoma	18172304	CNVD
Cancer	16751803	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Seminomas	18059402	CNVD
Testicular germ cell tumor	18059402	CNVD
Myxofibrosarcoma	16751306	CNVD
Breast cancer	16272173	CNVD
Ovarian cancer	21781307	CNVD
Lung cancer	18438408	CNVD
Mowat-Wilson syndrome	21572526	CNVD
Disorders of sex development	21048976	CNVD
epilepsy	18472482	CNVD
Ewing''s sarcoma	17952124	CNVD
Neuroblastoma	18574593	CNVD
Hepatocellular carcinoma	16750200	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Liposarcoma	21253554	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Autism	16446308	CNVD
Autism	19401682	CNVD
lymphocytic leukemia	21291569	CNVD
Breast cancer	21509527	CNVD
small cell lung cancer	20016488	CNVD
Ovarian clear cell carcinoma	19293255	CNVD
Myelofibrosis	22110671	CNVD
Intellectual disability	22045946	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Acute lymphoblastic leukemia	18458336	CNVD
Epilepsy	22083797	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD
Melanoma	20877625	CNVD
Non-syndromic sensorineural hearing loss	19587683	CNVD

Chromatin state (count:783 , 50 per page) page: 1 2 3 4 5 6 7 ... 16

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:96305400-96305600	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
2	chr2:96305600-96307400	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
3	chr2:96307400-96307600	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
4	chr2:96307400-96307600	Enhancers	NHDF-Ad	bronchial
5	chr2:96307400-96307800	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
6	chr2:96307400-96308400	Enhancers	Osteobl	bone
7	chr2:96307400-96308800	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
8	chr2:96307800-96308600	Weak transcription	NHDF-Ad	bronchial
9	chr2:96308000-96308400	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
10	chr2:96308200-96308400	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
11	chr2:96308200-96308400	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
12	chr2:96308400-96309400	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
13	chr2:96308600-96309600	Enhancers	NHDF-Ad	bronchial
14	chr2:96308800-96309200	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
15	chr2:96309200-96309600	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
16	chr2:96309400-96309800	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
17	chr2:96309800-96315000	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
18	chr2:96310800-96311200	Enhancers	Liver	Liver
19	chr2:96314600-96315400	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
20	chr2:96314600-96315400	Enhancers	Fetal Intestine Large	intestine
21	chr2:96314600-96315400	Enhancers	Fetal Intestine Small	intestine
22	chr2:96314800-96315200	Bivalent Enhancer	Fetal Muscle Trunk	muscle
23	chr2:96315000-96315400	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
24	chr2:96315200-96315400	Flanking Bivalent TSS/Enh	ES-I3 Cell Line	embryonic stem cell
25	chr2:96315200-96315400	Flanking Bivalent TSS/Enh	HUES48 Cell Line	embryonic stem cell
26	chr2:96315200-96315400	Flanking Bivalent TSS/Enh	HUES6 Cell Line	embryonic stem cell
27	chr2:96315200-96315400	Bivalent Enhancer	HUES64 Cell Line	embryonic stem cell
28	chr2:96315200-96315400	Bivalent Enhancer	iPS-15b Cell Line	embryonic stem cell
29	chr2:96315400-96315600	Bivalent Enhancer	HUES48 Cell Line	embryonic stem cell
30	chr2:96321600-96322600	Enhancers	Liver	Liver
31	chr2:96321600-96322600	Enhancers	Fetal Intestine Small	intestine
32	chr2:96322000-96322400	Enhancers	Fetal Intestine Large	intestine
33	chr2:96322600-96323200	Weak transcription	Fetal Intestine Small	intestine
34	chr2:96323200-96323400	Enhancers	Fetal Intestine Small	intestine
35	chr2:96326000-96329200	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
36	chr2:96326600-96326800	Enhancers	Lung	lung
37	chr2:96326800-96333600	Weak transcription	Lung	lung
38	chr2:96328000-96330600	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
39	chr2:96328200-96328800	Bivalent Enhancer	H9 Derived Neuron Cultured Cells	ES cell derived
40	chr2:96328200-96329000	Bivalent Enhancer	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
41	chr2:96328200-96330600	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
42	chr2:96328200-96336400	Weak transcription	Right Atrium	heart
43	chr2:96328400-96330000	Enhancers	Thymus	Thymus
44	chr2:96328600-96330400	Enhancers	Fetal Thymus	thymus
45	chr2:96328800-96329800	Enhancers	Fetal Lung	lung
46	chr2:96328800-96330000	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
47	chr2:96328800-96330000	Enhancers	Spleen	Spleen
48	chr2:96329000-96329400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
49	chr2:96329000-96329600	Bivalent Enhancer	Fetal Muscle Trunk	muscle
50	chr2:96329000-96329800	Enhancers	Cortex derived primary cultured neurospheres	brain

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links